Analgesic Solutions

Nov 05, 2018

Analgesic Solutions Presenting MADDERS® System at the Human Abuse Liability Testing and Market Access Meeting

Oct 22, 2018

Food and Drug Administration (FDA) Approval of GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences' EPIDIOLEX® (cannabidiol) CV Marks First Drug Approval and Scheduling Decision Supported by Analgesic Solutions' MADDERS® System

Oct 10, 2018

Analgesic Solutions Presenting MADDERS® System at the Advancements and Challenges in Abuse Potential Evaluation Meeting

Sep 21, 2018

Analgesic Solutions Announces New Executive Management Team

Jun 25, 2018

Analgesic Solutions Pain Research Methodology Applicable Across Therapeutic Spectrum

Jun 13, 2018

Analgesic Solutions Presents Data from the Implementation of its Misuse, Abuse, and Diversion Drug Event Reporting System (MADDERS®)

Jan 03, 2018

Jacqueline Delfgaauw, Ph.D. joins Analgesic Solutions as Executive Director, Clinical Science

Jun 19, 2017

Analgesic Solutions Presents Data on the use of MADDERS® to Assess Potentially Abuse-Related Events in Clinical Trials at the 79th Annual Scientific Meeting of The College on Problems of Drug Dependence